ConductScience.org, home

Paper15752

Clinical pharmacokinetics of sulphasalazine.

Das KM and 1 other. Clin Pharmacokinet, 1976. Cited by 184 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacokinetics of sulphasalazine. Papers, record 15752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of sulphasalazine.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
184
iCite
Relative citation ratio, by iCite
7.45
iCite
Revised in PubMed
2026-10-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Das KMK M
2Dubin RR

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SulfasalazineMajor topic
Acetylation
Animals
Anti-Bacterial Agents
Binding, Competitive
Calcium
Drug Interactions
Folic Acid
Humans
Intestinal Absorption
Iron
Kinetics
Phenobarbital
Phenotype
Protein Binding
Time Factors

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113952555Distribution and metabolism of salicyl-azo-sulfapyridine. I. A study with C-14-5-amino-salicylic acid.Acta Med Scand1963https://conductscience.org/library/papers/13952555PubMed
24400659[Treatment of radiation proctitis].Geburtshilfe Frauenheilkd1971https://conductscience.org/library/papers/4400659PubMed
34144775Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).Gastroenterology1973https://conductscience.org/library/papers/4144775PubMed
413994348Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.Br Med J1962https://conductscience.org/library/papers/13994348PubMed
64146457Salicylazosulfapyridine in clinical practice.Gastroenterology1973https://conductscience.org/library/papers/4146457PubMed
74155692Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.Gut1974https://conductscience.org/library/papers/4155692PubMed
84824571Respiratory disease due to sulphasalazine.Clin Allergy1974https://conductscience.org/library/papers/4824571PubMed
94402886Absorption, metabolism, and excretion of salicylazosulfapyridine in man.Clin Pharmacol Ther1972https://conductscience.org/library/papers/4402886PubMed
1013952556Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine.Acta Med Scand1963https://conductscience.org/library/papers/13952556PubMed
114393788Neurotoxicity associated with a reaction to sulphasalazine.Practitioner1970https://conductscience.org/library/papers/4393788PubMed
124151092Agranulocytosis associated with sulphasalazine therapy.Postgrad Med J1973https://conductscience.org/library/papers/4151092PubMed
134144706Effect of iron and calcium on salicylazosulphapyridine metabolism.Scott Med J1973https://conductscience.org/library/papers/4144706PubMed
1413722334Peripheral neuritis due to isoniazid.Bull World Health Organ1960https://conductscience.org/library/papers/13722334PubMed
164152289Fibrosing alveolitis and treatment with sulphasalazine.Gut1974https://conductscience.org/library/papers/4152289PubMed
174146729Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.N Engl J Med1973https://conductscience.org/library/papers/4146729PubMed
184402071Ulcerative postdysenteric colitis.Am J Gastroenterol1972https://conductscience.org/library/papers/4402071PubMed
1913760840An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.Gut1960https://conductscience.org/library/papers/13760840PubMed
205500003The metabolism of azo compounds: a review of the literature.Food Cosmet Toxicol1970https://conductscience.org/library/papers/5500003PubMed
214386858Unusual cause of yellow skin.Br Med J1968https://conductscience.org/library/papers/4386858PubMed
22235486Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.Gut1975https://conductscience.org/library/papers/235486PubMed

See all 67 referencesDownload CSV of references

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.

PMIDTitleJournalYearIn PapersSource
41675296
Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial.
EClinicalMedicine2026https://conductscience.org/library/papers/41675296PubMed
39598554Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.Pharmaceutics2024https://conductscience.org/library/papers/39598554PubMed
39329122Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database.Front Pharmacol2024https://conductscience.org/library/papers/39329122PubMed
38230664The aminosalicylate - folate connection.Drug Metab Rev2024https://conductscience.org/library/papers/38230664PubMed
37835065Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections.J Clin Med2023https://conductscience.org/library/papers/37835065PubMed
37160525Therapeutic drug monitoring of disease-modifying antirheumatic drugs in circulating leukocytes in immune-mediated inflammatory diseases.Inflammopharmacology2023https://conductscience.org/library/papers/37160525PubMed
34734308Immunosuppression in Rheumatologic and Auto-immune Disease.Handb Exp Pharmacol2022https://conductscience.org/library/papers/34734308PubMed
33671835Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry.Molecules2021https://conductscience.org/library/papers/33671835PubMed
32658475The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase.J Med Chem2020https://conductscience.org/library/papers/32658475PubMed
32157196Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response.Nat Rev Rheumatol2020https://conductscience.org/library/papers/32157196PubMed
29556907Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.Adv Ther2018https://conductscience.org/library/papers/29556907PubMed
25980667Pharmacogenetics of treatment response in psoriatic arthritis.Curr Rheumatol Rep2015https://conductscience.org/library/papers/25980667PubMed
24892773PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.Pharmacogenet Genomics2014https://conductscience.org/library/papers/24892773PubMed
24734245Digging up the human genome: current progress in deciphering adverse drug reactions.Biomed Res Int2014https://conductscience.org/library/papers/24734245PubMed
24394199Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis.Pharmacogenomics J2014https://conductscience.org/library/papers/24394199PubMed
19369484Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia.Mol Pharmacol2009https://conductscience.org/library/papers/19369484PubMed
15032315N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis.Pharm Res2004https://conductscience.org/library/papers/15032315PubMed
14722200Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs.Ann Rheum Dis2004https://conductscience.org/library/papers/14722200PubMed
11990379Pharmacogenetics of the arylamine N-acetyltransferases.Pharmacogenomics J2002https://conductscience.org/library/papers/11990379PubMed
8617147Pleuropericarditis related to the use of mesalamine.Dig Dis Sci1996https://conductscience.org/library/papers/8617147PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15752

GET https://conductscience.org/api/papers/v1/15752/references?page=2